Abstract: Light emitting compounds of the formula
where R1 is a light-emitting moiety, R2 is a CRF-related peptide and fragment, derivative or analog thereof and L is a linker moiety, which may be present or absent. The peptide is linked at a first amino acid position to (C—X) which, in turn, is selected from the group including C═O, C═S, CH(OH), C═C═O, C═NH, CH2, CH(OR), CH(NR), CH(R), CR3R4, and C(OR3)OR4 where R, R3, and R4 are alkyl moieties or substituted alkyl moieties. Optionally the compound may include a linker moiety between the peptide and the C—X binding group. Preferably, the compound exhibits substantial biological activity in the presence of receptors having affinities for CRF-related peptides.
Type:
Grant
Filed:
July 19, 1999
Date of Patent:
January 20, 2004
Assignee:
Advanced Bioconcept Company
Inventors:
Clarissa Desjardins, Jacek Slon-Usakiewicz, Katherine J. Bonter
Abstract: Light emitting compounds of the formula:
where R1 is a light-emitting moiety and R2 is a motilin peptide and fragment, derivative or analog thereof The peptide is linked at a first amino acid position to (C—X) which, in turn, is selected from the group including C═O, C═S, CH(OH), C═C═O, C═NH, CH2, CH(OR), CH(NR), CH(R), CR3R4, and C(OR3)OR4 where R, R3, and R4 are alkyl moieties or substituted alkyl moieties. Optionally the compound may include a linker moiety between the peptide and the C—X binding group. Preferably, the compound exhibits substantial biological activity in the presence of receptors having affinities for motilin peptides.
Type:
Grant
Filed:
March 31, 2000
Date of Patent:
January 13, 2004
Assignee:
Advanced Bioconcept Company
Inventors:
Clarissa Desjardins, Jacek Slon-Usakiewicz, Katherine J. Bonter